Last month I wrote an open letter, as Chair of the International Institute of Psychiatric Drug Withdrawal, requesting that the UK’s National Institute for Health and Care Excellence (NICE) reverse its ...

Safety signals spanning decades have not removed many high-risk psychiatric drugs from the market, prompting renewed scrutiny of federal regulators ...

Addiction has causes that are neurobiological, psychological and structural. Treating these drivers is as important as managing the initial withdrawal. Medically managed withdrawal does not restore ...

The global withdrawal of voxelotor (Oxbryta, Pfizer) has left clinicians who treat sickle cell disease (SCD) with the urgent task of reaching patients taking the medicine, while trying to understand ...

Finerenone, a third-generation nonsteroidal mineralocorticoid receptor antagonist, showed promise in reducing the incidence of cardiovascular events in patients with heart failure (HF). However, its ...

Dominic Cipriano couldn’t stop shaking. A drug dealer on the streets of Kensington had sold him a bag of what he thought was fentanyl. But whatever Cipriano had taken didn’t produce the familiar rush ...

Stopping treatment with Mounjaro doesn’t cause withdrawal symptoms. But, it can cause certain symptoms to return as the drug leaves your system, such as nausea, constipation, or irritability. Changes ...

Researchers find that a common glaucoma drug, acetazolamide, can reverse brain changes and prevent relapse in opioid use disorder.